Development of an Accurate Bedside Swallowing Evaluation Decision Tree Algorithm for Detecting Aspiration in Acute Respiratory Failure Survivors.


Journal

Chest
ISSN: 1931-3543
Titre abrégé: Chest
Pays: United States
ID NLM: 0231335

Informations de publication

Date de publication:
11 2020
Historique:
received: 27 01 2020
revised: 06 07 2020
accepted: 12 07 2020
pubmed: 30 7 2020
medline: 28 5 2021
entrez: 30 7 2020
Statut: ppublish

Résumé

The bedside swallowing evaluation (BSE) is an assessment of swallowing function and airway safety during swallowing. After extubation, the BSE often is used to identify the risk of aspiration in acute respiratory failure (ARF) survivors. We conducted a multicenter prospective study of ARF survivors to determine the accuracy of the BSE and to develop a decision tree algorithm to identify aspiration risk. Patients extubated after ≥ 48 hours of mechanical ventilation were eligible. Study procedures included the BSE followed by a gold standard evaluation, the flexible endoscopic evaluation of swallowing (FEES). Overall, 213 patients were included in the final analysis. Median time from extubation to BSE was 25 hours (interquartile range, 21-45 hours). The FEES was completed 1 hour after the BSE (interquartile range, 0.5-2 hours). A total of 33% (70/213; 95% CI, 26.6%-39.2%) of patients aspirated on at least one FEES bolus consistency test. Thin liquids were the most commonly aspirated consistency: 27% (54/197; 95% CI, 21%-34%). The BSE detected any aspiration with an accuracy of 52% (95% CI, 45%-58%), a sensitivity of 83% (95% CI, 74%-92%), and negative predictive value (NPV) of 81% (95% CI, 72%-91%). Using recursive partitioning analyses, a five-variable BSE-based decision tree algorithm was developed that improved the detection of aspiration with an accuracy of 81% (95% CI, 75%-87%), sensitivity of 95% (95% CI, 90%-98%), and NPV of 97% (95% CI, 95%-99%). The BSE demonstrates variable accuracy to identify patients at high risk for aspiration. Our decision tree algorithm may enhance the BSE and may be used to identify patients at high risk for aspiration, yet requires further validation. ClinicalTrials.gov; No.: NCT02363686; URL: www.clinicaltrials.gov.

Sections du résumé

BACKGROUND
The bedside swallowing evaluation (BSE) is an assessment of swallowing function and airway safety during swallowing. After extubation, the BSE often is used to identify the risk of aspiration in acute respiratory failure (ARF) survivors.
RESEARCH QUESTION
We conducted a multicenter prospective study of ARF survivors to determine the accuracy of the BSE and to develop a decision tree algorithm to identify aspiration risk.
STUDY DESIGN AND METHODS
Patients extubated after ≥ 48 hours of mechanical ventilation were eligible. Study procedures included the BSE followed by a gold standard evaluation, the flexible endoscopic evaluation of swallowing (FEES).
RESULTS
Overall, 213 patients were included in the final analysis. Median time from extubation to BSE was 25 hours (interquartile range, 21-45 hours). The FEES was completed 1 hour after the BSE (interquartile range, 0.5-2 hours). A total of 33% (70/213; 95% CI, 26.6%-39.2%) of patients aspirated on at least one FEES bolus consistency test. Thin liquids were the most commonly aspirated consistency: 27% (54/197; 95% CI, 21%-34%). The BSE detected any aspiration with an accuracy of 52% (95% CI, 45%-58%), a sensitivity of 83% (95% CI, 74%-92%), and negative predictive value (NPV) of 81% (95% CI, 72%-91%). Using recursive partitioning analyses, a five-variable BSE-based decision tree algorithm was developed that improved the detection of aspiration with an accuracy of 81% (95% CI, 75%-87%), sensitivity of 95% (95% CI, 90%-98%), and NPV of 97% (95% CI, 95%-99%).
INTERPRETATION
The BSE demonstrates variable accuracy to identify patients at high risk for aspiration. Our decision tree algorithm may enhance the BSE and may be used to identify patients at high risk for aspiration, yet requires further validation.
TRIAL REGISTRY
ClinicalTrials.gov; No.: NCT02363686; URL: www.clinicaltrials.gov.

Identifiants

pubmed: 32721404
pii: S0012-3692(20)32076-6
doi: 10.1016/j.chest.2020.07.051
pmc: PMC7674978
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT02363686']

Types de publication

Clinical Trial Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1923-1933

Subventions

Organisme : NHLBI NIH HHS
ID : K24 HL089223
Pays : United States
Organisme : NINR NIH HHS
ID : R21 NR015886
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Références

Transfusion. 2019 Mar;59(3):953-964
pubmed: 30548461
Clin Otolaryngol Allied Sci. 2000 Dec;25(6):504-6
pubmed: 11122289
Ann Otol Rhinol Laryngol. 2015 Mar;124(3):206-11
pubmed: 25204714
J Clin Neurol. 2018 Jul;14(3):265-274
pubmed: 29504298
Arch Otolaryngol Head Neck Surg. 2001 Jul;127(7):870-6
pubmed: 11448365
Dysphagia. 2020 Dec;35(6):968-977
pubmed: 32103328
Dysphagia. 2000 Spring;15(2):84-8
pubmed: 10758190
J Neurotrauma. 2005 Oct;22(10):1040-51
pubmed: 16238482
J Commun Disord. 2001 Jan-Apr;34(1-2):55-72
pubmed: 11322570
J Crit Care. 2012 Dec;27(6):578-86
pubmed: 23084136
Cancer. 1990 Aug 1;66(3):564-9
pubmed: 2364368
Laryngoscope. 2007 Oct;117(10):1723-7
pubmed: 17906496
Age Ageing. 2000 Nov;29(6):495-9
pubmed: 11191240
Support Care Cancer. 2014 Mar;22(3):595-602
pubmed: 24141700
Crit Care. 2011;15(5):R231
pubmed: 21958475
Dysphagia. 2000 Spring;15(2):58-67
pubmed: 10758187
Crit Care Med. 2006 Apr;34(4):1007-15
pubmed: 16484901
Clin Otolaryngol. 2006 Oct;31(5):425-32
pubmed: 17014453
Clin Nutr Res. 2019 Oct 25;8(4):265-271
pubmed: 31720252
Int J Radiat Oncol Biol Phys. 2008 Dec 1;72(5):1355-61
pubmed: 18501527
Semin Speech Lang. 2019 Jun;40(3):170-187
pubmed: 31158902
Laryngoscope. 1997 Mar;107(3):396-401
pubmed: 9121321
J Voice. 2007 Sep;21(5):576-90
pubmed: 16822648
J Acad Nutr Diet. 2015 Jan;115(1):106-11
pubmed: 25441963
J Neurol Neurosurg Psychiatry. 1997 Oct;63(4):456-60
pubmed: 9343123
Stroke. 2003 May;34(5):1252-7
pubmed: 12677020
Age Ageing. 1998 Mar;27(2):99-106
pubmed: 16296668
J Commun Disord. 2004 Sep-Oct;37(5):437-50
pubmed: 15231424
J Hosp Med. 2015 Apr;10(4):256-65
pubmed: 25581840
Dysphagia. 2015 Aug;30(4):418-22
pubmed: 25943296
Ann Otol Rhinol Laryngol. 2019 Jul;128(7):619-624
pubmed: 30841709
Dysphagia. 1996 Spring;11(2):93-8
pubmed: 8721066
Dysphagia. 2008 Sep;23(3):244-50
pubmed: 18058175
Can J Surg. 2009 Apr;52(2):119-24
pubmed: 19399206
J Speech Lang Hear Res. 2005 Dec;48(6):1280-93
pubmed: 16478371
J Clin Nurs. 2014 Jul;23(13-14):1908-15
pubmed: 24033866
Chest. 2010 Mar;137(3):665-73
pubmed: 20202948
Crit Care Med. 2017 Dec;45(12):2061-2069
pubmed: 29023260
Stroke. 2009 Feb;40(2):555-61
pubmed: 19074483
Dysphagia. 2002 Fall;17(4):308-15
pubmed: 12355146
Dysphagia. 2011 Sep;26(3):304-9
pubmed: 21063732
Chest. 2002 May;121(5):1602-9
pubmed: 12006450
Crit Care Med. 2010 Oct;38(10):1947-53
pubmed: 20639743
JPEN J Parenter Enteral Nutr. 2007 Jul-Aug;31(4):269-73
pubmed: 17595433
Dysphagia. 2014 Feb;29(1):33-43
pubmed: 23828313
Ann Otol Rhinol Laryngol. 2015 Jul;124(7):537-44
pubmed: 25667217
Dysphagia. 2013 Jun;28(2):205-11
pubmed: 23179025
J Crit Care. 2017 Jun;39:143-148
pubmed: 28259057
Stroke. 2005 Dec;36(12):2756-63
pubmed: 16269630
Am J Phys Med Rehabil. 2020 Dec;99(12):1164-1170
pubmed: 32304381
Chest. 2016 Jul;150(1):148-63
pubmed: 27102184
Dysphagia. 2002 Summer;17(3):214-8
pubmed: 12140648
Intensive Care Med. 2003 Sep;29(9):1451-5
pubmed: 12904855
Arch Intern Med. 1989 Sep;149(9):1937-41
pubmed: 2505703
Dysphagia. 2017 Apr;32(2):293-314
pubmed: 27913916
BMJ. 2015 Oct 28;351:h5527
pubmed: 26511519

Auteurs

Marc Moss (M)

Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Denver, Aurora, CO. Electronic address: marc.moss@CUAnschutz.edu.

S David White (SD)

University of Colorado Denver Rehabilitation Therapy Services, University of Colorado Hospital, Aurora, CO.

Heather Warner (H)

Section of Otolaryngology, Department of Surgery, Yale School of Medicine, New Haven, CT; Department of Communication Disorders, Southern Connecticut State University, New Haven, CT.

Daniel Dvorkin (D)

Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Denver, Aurora, CO; The Bioinformatics CRO, Inc, Niceville, FL.

Daniel Fink (D)

Department of Otolaryngology, University of Colorado School of Medicine, Aurora, CO.

Stephanie Gomez-Taborda (S)

Department of Otolaryngology, Boston Medical Center, Boston, MA.

Carrie Higgins (C)

Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Denver, Aurora, CO.

Gintas P Krisciunas (GP)

Department of Otolaryngology, Boston Medical Center, Boston, MA; Department of Otolaryngology, Boston University School of Medicine, Boston, MA.

Joseph E Levitt (JE)

Division of Pulmonary and Critical Care, Stanford University, Stanford, CA.

Jeffrey McKeehan (J)

Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Denver, Aurora, CO.

Edel McNally (E)

Department of Otolaryngology, Boston Medical Center, Boston, MA; Sargent College of Health and Rehabilitation Sciences, Boston University, Boston, MA.

Alix Rubio (A)

Department of Otolaryngology, Boston Medical Center, Boston, MA.

Rebecca Scheel (R)

Sargent College of Health and Rehabilitation Sciences, Boston University, Boston, MA; Division of Speech Language Pathology, Massachusetts General Hospital, Boston, MA.

Jonathan M Siner (JM)

Section of Pulmonary, Critical Care, and Sleep Medicine, Yale School of Medicine, New Haven, CT.

Rosemary Vojnik (R)

Division of Pulmonary and Critical Care, Stanford University, Stanford, CA.

Susan E Langmore (SE)

Department of Otolaryngology, Boston Medical Center, Boston, MA; Department of Otolaryngology, Boston University School of Medicine, Boston, MA; Sargent College of Health and Rehabilitation Sciences, Boston University, Boston, MA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH